Stocks and Investing
by (remove) : Cecilia Furlong
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Cecilia Furlong
RSSJSONXMLCSV
Mon, July 15, 2024
Wed, February 28, 2024
Mon, December 4, 2023
Wed, November 8, 2023
Tue, November 7, 2023
Tue, October 31, 2023
Fri, October 13, 2023
Wed, August 2, 2023
Wed, May 31, 2023
Thu, May 11, 2023
Mon, May 8, 2023
Wed, May 3, 2023
Fri, April 28, 2023
Thu, April 27, 2023
Thu, February 23, 2023
Fri, February 10, 2023
Mon, February 6, 2023
Fri, January 6, 2023
Thu, November 17, 2022
Fri, November 4, 2022
Thu, November 3, 2022
Thu, October 20, 2022

Cecilia Furlong Maintained (ZBH) at Hold with Decreased Target to $120 on, Jul 15th, 2024


Published on 2024-10-28 12:27:37 - WOPRAI, Cecilia Furlong
  Print publication without navigation


Cecilia Furlong of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Hold with Decreased Target from $130 to $120 on, Jul 15th, 2024.

Cecilia has made no other calls on ZBH in the last 4 months.



There are 9 other peers that have a rating on ZBH. Out of the 9 peers that are also analyzing ZBH, 6 agree with Cecilia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joanne Wuensch of "Citigroup" Maintained at Hold with Decreased Target to $120 on, Wednesday, July 10th, 2024
  • Vijay Kumar of "Evercore ISI Group" Maintained at Hold with Decreased Target to $115 on, Tuesday, July 2nd, 2024
  • Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $115 on, Monday, July 1st, 2024
  • David Roman of "Goldman Sachs" Initiated at Hold and Held Target at $129 on, Thursday, May 30th, 2024
  • Mike Matson of "Needham" Reiterated at Hold on, Thursday, May 30th, 2024
  • Richard Newitter of "Truist Securities" Maintained at Hold with Decreased Target to $130 on, Friday, May 3rd, 2024


These are the ratings of the 3 analyists that currently disagree with Cecilia


  • Matt Miksic of "Barclays" Maintained at Sell with Decreased Target to $125 on, Friday, May 31st, 2024
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $150 on, Tuesday, May 21st, 2024
  • Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $155 on, Friday, May 3rd, 2024
Contributing Sources